Cargando…

Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA

INTRODUCTION: There is little understanding of long-term treatment persistence in patients receiving anti-vascular endothelial growth factor (anti-VEGF) injections for diabetic macular edema (DME), particularly relating to treatment intervals. The aim of this study was to investigate the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakri, Sophie J., Delyfer, Marie-Noelle, Grauslund, Jakob, Andersen, Steffen, Karcher, Helene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441838/ https://www.ncbi.nlm.nih.gov/pubmed/37347405 http://dx.doi.org/10.1007/s40123-023-00750-9

Ejemplares similares

Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review
por: Kodjikian, Laurent, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
por: Kim, Moosang
Publicado: (2016)

Anti-vascular endothelial growth factor in the treatment of macular edema in epidemic retinitis
por: Kawali, Ankush A, et al.
Publicado: (2020)

Progress of Diabetic Macular Edema after Loading Injection of Anti-Vascular Endothelial Growth Factor Agents in Real-World Cases
por: Enomoto, Hiroko, et al.
Publicado: (2022)

Intravitreal triamcinolone for intraocular inflammation and associated macular edema
por: Couch, Steven M, et al.
Publicado: (2009)

Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
por: Baillif, Stéphanie, et al.
Publicado: (2022)

Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
por: Larsen, Helene O., et al.
Publicado: (2023)

Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
por: Matonti, Frédéric, et al.
Publicado: (2022)

Incidence of Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty
por: Kocaba, Viridiana, et al.
Publicado: (2018)

Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction
por: Okawada, Hideaki, et al.
Publicado: (2018)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
por: Ratra, Dhanashree
Publicado: (2021)

Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
por: Li, Yun-Fei, et al.
Publicado: (2022)

Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan
por: Sugimoto, Masahiko, et al.
Publicado: (2018)

Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms
por: Bormann, Caroline, et al.
Publicado: (2017)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Bhagat, Davis, et al.
Publicado: (2020)

Modeling Time Effects in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema – A Mixed Model Analysis of Real-World Data
por: Mylona, Ioanna, et al.
Publicado: (2020)

Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2020)

Use of antivascular endothelial growth factor for diabetic macular edema
por: Karim, Rushmia, et al.
Publicado: (2010)

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
por: Mashima, Asako, et al.
Publicado: (2019)

Relief of Cystoid Macular Edema-Induced Focal Axonal Compression with Anti-Vascular Endothelial Growth Factor Treatment
por: Karahan, Eyyup, et al.
Publicado: (2020)

Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema
por: Gurung, Rajya L., et al.
Publicado: (2022)

Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis
por: Wang, Xian, et al.
Publicado: (2022)

Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor
por: Savur, Fatma, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan
por: Komori, Ryohei, et al.
Publicado: (2022)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Arteriovenous Sheathotomy for Persistent Macular Edema in Branch Retinal Vein Occlusion
por: Sohn, Joon Hong, et al.
Publicado: (2006)

Foveal Eversion: A Possible Biomarker of Persistent Diabetic Macular Edema
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
por: Thinggaard, Benjamin Sommer, et al.
Publicado: (2023)

Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
por: Fujikawa, Masato, et al.
Publicado: (2013)

Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs
por: Ibrahim, Walid S., et al.
Publicado: (2019)

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
por: Dou, Ningxin, et al.
Publicado: (2021)

Prevalence of bacillary layer detachment in diabetic macular edema and response to 3 anti-vascular endothelial growth factor treatment
por: Chen, Yann-Guang, et al.
Publicado: (2023)

Modified early intensive and treat-and-extend regimen of anti-vascular endothelial growth factor for diabetic macular edema in Taiwan
por: Chou, Jui-Feng, et al.
Publicado: (2023)

Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study
por: Peto, Tunde, et al.
Publicado: (2021)

The Role of Inflammation in the Pathogenesis of Macular Edema Secondary to Retinal Vascular Diseases
por: Ascaso, Francisco J., et al.
Publicado: (2014)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
por: Grzybowski, Andrzej, et al.
Publicado: (2021)

Evaluation of markers of outcome in real-world treatment of diabetic macular edema
por: Campos, António, et al.
Publicado: (2018)

Cystoid macular edema
por: Rotsos, Tryfon G, et al.
Publicado: (2008)

Diabetic Macular Edema
por: Gundogan, Fatih C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f6gibq0ge4i8qmqm2idq51nird